# Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

> **NCT07470593** · — · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 36 (estimated)

## Conditions studied

- Type 1 Diabetes (T1D)

## Interventions

- **OTHER:** Continuous glucose monitoring (CGM) with TITR measurement

## Key facts

- **NCT ID:** NCT07470593
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2029-12-15
- **Final completion:** 2029-12-15
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07470593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07470593, "Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07470593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*